Market Cap
$14.97 Billion
USD as of Jan. 1, 2025
Company | Market Cap (USD) |
---|---|
![]() |
$219.88 B |
![]() |
$177.43 B |
![]() |
$59.19 B |
![]() |
$43.57 B |
![]() |
$41.66 B |
Company | Market Cap (USD) |
---|---|
![]() |
$689.42 B |
![]() |
$622.07 B |
![]() |
$487.54 B |
![]() |
$353.05 B |
![]() |
$301.60 B |
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Revvity, Inc., formerly part of PerkinElmer, Inc., offers solutions for diagnostics and life sciences markets globally. It provides tools for life science research, environmental analysis, industrial processes, and genomic workflows via two segments: Discovery & Analytical Solutions and Diagnostics. The latter focuses on early disease detection, including genetic disorders. Established in 1937, it serves a broad range of sectors, from pharmaceuticals to academia.
Revvity, Inc. has the following listings and related stock indices.
Stock: NYSE: RVTY
The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.